Login
← Go Back
FDC
FDC · Pharma > Pharmaceuticals & Drugs · Chairman: Uday Kumar Gurkar · MD: Mohan A Chandavarkar · Listing date: Aug. 8, 1997 · Employees: 5519 · Mumbai · http://www.fdcindia.com
Stock Price vs Company Growth
1d
2.3%
1w
0.9%
1m
2.7%
3m
9.7%
6m
12.1%
1y
18.0%
5y
4.1%
10y
6.7%
all
14.8%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 419 2.3%
402
528
Company Overview
Sales
2,077 Cr
Growth: 5.1%
Profit after Tax
225 Cr
Growth: -16.2%
Small Cap
6,814 Cr
P/E: 30.2x
Industry P/E: 33.1x
Fundamentals
Sales (Cr) ₹ 2,077
Growth 5.1%
EBITDA 13.2%
P/S 3.3x
Dividend 1.0%
P/E 30.2x
Book Value ₹ 149
PEG Ratio 6.0x
ROE 9.6%
P/B 2.8x
Shareholding Pattern
Institutions
Nippon Life India Trustee Ltd-A/C Nippon India Small Cap Fund
2.58 %
Fidelity Puritan Trust-Fidelity Low-Priced Stock Fund
1.49 %
Promoters
Meera Ramdas Chandavarkar
19.36 %
Nandan Mohan Chandavarkar
10.96 %
Nandan Mohan Chandavarkar
10.77 %
Leo Advisors Pvt Ltd
9.13 %
Virgo Advisors Pvt Ltd
6.09 %
Others
Bengal Finance And Investment Pvt Ltd
1.08 %
Iepf
0.15 %
Increase    Decrease    No change
Company Profile Detailed
FDC Limited is among India’s leading fully integrated pharmaceutical companies. The Company is a pioneer in the manufacture of specialised formulations, and among the world’s foremost manufacturers and marketers of Oral Rehydration Salts (ORS). Over its long history of 85 years, the Company has maintained a distinguished reputation for high-quality, affordable products and built a market-leading brand portfolio.
Belongs to (10 Indices) view more
Investors (67)
nse.clea...
tata.val...
leo.advi...
Followers (6)
deepak
nitin2
keerthi